Hanjin Kal
KRX:18064K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hanjin Kal
KRX:18064K
|
KR |
|
Concordia Financial Group Ltd
F:YC3
|
JP |
|
S
|
Stelrad Group PLC
F:6OJ
|
UK |
|
P
|
PT Temas Tbk
XMUN:P5TA
|
ID |
|
S
|
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
XBER:FDY
|
CN |
|
P
|
PCCW Ltd
XMUN:TH3B
|
HK |
|
Katitas Co Ltd
OTC:KTITF
|
JP |
|
I
|
Ironwood Pharmaceuticals Inc
F:I76
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 18064K's stock price target?
Not Available
18064K does not have any price targets made by Wall Street professionals.
What is the Gross Profit forecast for Hanjin Kal?
Projected CAGR
-14%
Over the last 11 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 3 years is -14%.
What is the Pre-Tax Income forecast for Hanjin Kal?
Projected CAGR
45%
Over the last 11 years, the compound annual growth rate for Pre-Tax Income has been -8%. The projected CAGR for the next 3 years is 45%.
What is the Net Income forecast for Hanjin Kal?
Projected CAGR
78%
Over the last 11 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 3 years is 78%.
